Senior insider sale
Chief Executive Officer at SPYRE THERAPEUTICS, INC. — senior position signals high conviction
$3.53M
90K shares
What this filing means
TURTLE CAMERON plans to sell 90K shares of SPYRE THERAPEUTICS, INC. valued at approximately $3.53M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/2/2026ACC: 0001950047-26-001983
DirectorOfficer· Chief Executive Officer
Since Mar 2026
90K
Shares to sell
$3.53M
Approx. market value
60K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Previously Exercised Stock Options
Cash
6/15/2023
60KTotal acquired60K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/15/2023 | Previously Exercised Stock Options Cash | 60K | — |
| Total | 60K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
15K
Market value
$492.1K
2/2/2026
—Completed
Units to sell
15K
Market value
$460.1K
1/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
60K
Market value
$2.58M
3/2/2026
Total
Units
90K
Value
$3.53M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/2/2026 | 15K | $492.1K | — | Completed |
1/2/2026 | 15K | $460.1K | — | Completed |
| Planned — Approximate Date | ||||
3/2/2026 | 60K | $2.58M | NASDAQ | Planned |
| Total | 90K | $3.53M | ||